Testing YB-101 for safety and effectiveness in Graves' disease
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests an investigational drug called YB-101 for people with Graves' disease, whether or not they have thyroid eye disease. The goal is to see if the drug is safe and can help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Graves' disease, confirmed by a blood test for thyroid-stimulating hormone receptor antibodies (TRAbs).
- You either have thyroid eye disease (TED) or have no signs of it during an eye exam.
- You have not been treated with radioactive iodine or had your thyroid gland removed.
- You have not taken thyroid hormone medications (like levothyroxine) in the last 6 weeks.
- You are not currently using or have not recently used the drug teprotumumab.
- Your hyperthyroidism is caused by Graves' disease, not by other conditions like a toxic nodule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
This trial is testing a new drug, BHV-1300, to see if it works and is safe for people with Graves' disease. It might be an option if you have active hyperthyroidism (overactive thyroid) caused by Graves' disease and haven't had certain other treatments.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This study tests a new medication called MER511 for adults with Graves' disease. The goal is to see if it is safe and how it works when taken once or multiple times.
This study tests a new investigational drug called GensSci098 for people with Graves' disease who have not taken antithyroid medication recently. It aims to see if the drug can help manage thyroid hormone levels.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.